SF 1026 (see companion bill HF 815) – Minnesota

Status: Inactive / Dead
Year Introduced: 2019
Link: https://www.revisor.mn.gov/bills/bill.php?f=SF1026&y=2019&ssn=0&b=senate

Step therapy override procedures application to state public care programs requirement. Under current law, health plan companies must allow enrollees and prescribing providers to request an override of a step therapy requirement for a prescription drug. The MA and MinnesotaCare programs are exempted from this requirement. This bill eliminates this exemption for MA and MinnesotaCare, and requires these programs to make a step therapy override process available to MA and MinnesotaCare enrollees and participating providers.

Return to Database Search

© 2018- The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found